FDA approves rapid-acting inhaled insulin for children
Medical Xpress - medical research advances and health news [Uno…
June 12, 2026
The U.S. Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 or type 2 diabetes.
Discussion in the ATmosphere